Vida Ventures Advisors

Latest statistics and disclosures from Vida Ventures Advisors's latest quarterly 13F-HR filing:

Tip: Access up to 7 years of quarterly data

Positions held by Vida Ventures Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Portfolio Holdings for Vida Ventures Advisors

Vida Ventures Advisors holds 7 positions in its portfolio as reported in the December 2023 quarterly 13F filing

Company (Ticker) Portfolio Weight Valued At Change in Shares Share Count Share Price
Centessa Pharmaceuticals Ordinary Shares (CNTA) 37.3 $31M 3.9M 7.96
 View chart
Dyne Therapeutics Common Stock (DYN) 32.9 $28M -6% 2.1M 13.30
 View chart
LianBio Ordinary Shares (LIAN) 12.1 $10M 2.3M 4.47
 View chart
Allogene Therapeutics Common Stock (ALLO) 6.9 $5.8M 1.8M 3.21
 View chart
Kinnate Biopharma Common Stock (KNTE) 6.2 $5.2M 2.2M 2.37
 View chart
Kronos Bio Common Stock (KRON) 4.1 $3.5M 2.8M 1.25
 View chart
Ikena Oncology Common Stock (IKNA) 0.5 $444k 225k 1.97
 View chart

Past Filings by Vida Ventures Advisors

SEC 13F filings are viewable for Vida Ventures Advisors going back to 2020